Systems, methods, and devices for ozone sanitization of continuous positive airway pressure devices

Abstract
Technologies for sanitizing a medical instrument with ozone are described. In particular, systems, methods, and devices for sanitizing a continuous positive airway pressure (CPAP) device are disclosed. The systems and device include an ozone compartment, an ozone operating system and one or more ozone distribution lines that distribute ozone to a continuous positive airway pressure device. The device may further include a heater adapter unit to connect heating systems in CPAP devices while distributing ozone to sanitize the CPAP device.
Description
FIELD OF THE INVENTION

The present invention is generally related to a device and method for disinfecting a medical instrument with ozone, in particular the invention relates to a device and method for disinfecting a continuous positive airway pressure (CPAP) device.


BACKGROUND OF THE INVENTION

Sleep apnea is a common sleep disorder characterized by abnormal breathing during sleep. Pauses in breathing for people with sleep apnea can last from a few seconds to minutes during sleep, often resulting in significant levels of sleep disturbance, which may result in daytime fatigue, impaired reaction time, vision problems, and impaired daytime cognition.


Sleep apnea is often treated with a continuous positive airway pressure (CPAP) device. CPAP devices prevent reduction of oxygen levels in the blood and sleep loss by delivering a stream of pressured air through a hose to a nasal pillow or full facemask surrounding a patient's nose. The CPAP devices work by blowing air at a prescribed pressure for each patient, and keeping the air passage open to maintain unobstructed breathing throughout a sleep period.


While CPAP treatment can be a highly effective treatment for sleep apnea, a major downside with CPAP treatment is non-compliance by users. Users are often reluctant to continuously use CPAP devices because the nose and face masks may be uncomfortable. In addition, maintenance of many CPAP devices has proved to be tiring and difficult for users, as water vapor running through the hoses and masks of a device may cause bacterial build-up and require continuous cleaning and prevention as necessary steps to safely use a device, which may result in further non-compliance by users. Most manufacturers of CPAP devices recommend that users perform daily and weekly maintenance on their machines to prevent bacteria and mold buildup. In this instance, each part of the CPAP device needs to be cleaned individually, including the mask, the hoses and the humidification portion, which is difficult and time consuming for users on a daily or weekly basis. Other CPAP device cleaning methods include soaking the component parts of a CPAP device in a mixture of vinegar and water to disinfect the component parts. Because of the inherent nature for CPAP devices to collect bacteria and mold, a number of other products are available to consumers to make CPAP machines safer, including but not limited to:


Citrus II Cleaning Spray for masks and tubing, available at www.cpapxchange.com


Contour CPAP cleaning wipes


CPAP tube cleaning brushes, available at www.cpapxchange.com


CPAP Guardian, available at www.cpapguardian.com


Further, several patents and patent applications have been filed on CPAP devices, improvements and the like. The patents in the field of CPAP devices include U.S. Pat. Nos. 8,146,946, 8,051,853, 7,794,522, 7,845,350, 7,676,276, 6,276,304, 7,527,603, 7,767,168, 6,752,151, 6,280,633, 7,022,225, 4,787,980 and US application numbers: 20100111792, 20060130834, 20040251125, 20050186108.


While some of the existing products, patents and applications described above refer to CPAP systems, methods and devices, there is no system, method or device shown that describes an automated disinfecting system or method for a CPAP device, for ease of use of users and to improve user compliance. In addition, the use of ozone to sanitize, disinfect and clean CPAP devices is a long felt need in the art as a safe and easy disinfectant system for improved compliance of a user, as described in accordance with the present invention.


Other systems, methods, device features, and advantages of the present invention will be or become apparent to one with skill in the art upon examination of the following drawings and detailed description. It is intended that all such additional systems, methods, device features, and advantages be included within this description, be within the scope of the present invention, and be protected by the accompanying claims.





BRIEF DESCRIPTION OF THE DRAWINGS

Many aspects of the invention can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present invention. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.



FIG. 1 is a perspective view of an ozone device connected to a CPAP device, in accordance with one embodiment of the invention.



FIG. 2 is a side-view of a CPAP connector unit and a hose connecting to a water reservoir, in accordance with one embodiment of the invention.



FIG. 3 is a perspective view of an ozone device connected to a CPAP device, in accordance with one embodiment of the invention.



FIG. 4 is a top view of a water reservoir and hose with free ozone, in accordance with one embodiment of the present invention.



FIG. 5 is a side view of a CPAP connector unit and a heater adapter unit connecting a hose to a CPAP device in accordance with one embodiment of the present invention.



FIG. 5A is a side view of a CPAP connector unit and a heater adapter unit connecting a hose to a CPAP device in accordance with one embodiment of the present invention.



FIG. 6 is a side view of a CPAP device with a heating element, connected to the CPAP device with a continuous positive airway connector unit in accordance with one embodiment of the present invention.



FIG. 7 is a side view of a CPAP device with a heating element, connected with a heater adapter unit in accordance with one embodiment of the present invention.



FIG. 8 is a perspective view of a CPAP device with a heating element connected to the CPAP device with a heater adapter unit.



FIG. 9 is a front view of a CPAP mask, in accordance with a one embodiment of the present invention.



FIG. 10 is a side view of a CPAP mask and straps, in accordance with another embodiment of the present invention.





DETAILED DESCRIPTION


FIG. 1 shows a perspective view of an ozone device 100 connected to a CPAP device 105. In this embodiment an ozone compartment 110 for housing an ozone operating system 115 is shown in the ozone device 100. In accordance with this embodiment, the ozone operating system 115 produces and transfers ozone to the CPAP device 105 to disinfect the CPAP device 105 before or after use by a user.


In accordance with this embodiment, the ozone operating system 115 pulls in ambient air into an air pump to create ozone. The air pump may transfer the ambient air to a corona discharge ozone generator, which may create about 400 mg/hr of ozone gas, which may be used to disinfect a CPAP device 105. In accordance with this embodiment, the ozone may be pumped directly into the CPAP device 105 and/or a water reservoir tank 122 from the ozone compartment 110 through an ozone distribution line 118 that connects to the CPAP connector unit 130, for providing ozone to disinfect the CPAP device 105. In accordance with the device shown in FIG. 1 the ozone may enter the ozone distribution line 118 when powered by a small air pump, such as an aquarium pump, and then migrate through the distribution line 118, through a CPAP connector unit 130, and into the water reservoir 122. The ozone distribution line 118 traverses into the hose 124 and the CPAP connector unit 130 and ends with a free end immersed in the CPAP water reservoir 122. The ozone may then be released into water in the water reservoir 122, acting to disinfect and sanitize the water reservoir 122, and may then release as free ozone from the water in the water reservoir 122. The free ozone may then traverse into the hose 124, which then carries the ozone into a mask compartment 116 to sanitize a mask 112. Within about 20-30 minutes from the start of the ozone sanitizing process described, the ozone will naturally breakdown into oxygen O2, resulting in a CPAP device 100 with an automated disinfecting process with ozone passing through and disinfecting the CPAP water reservoir 122, the water in the reservoir, the hose 124, the mask compartment 116 and the mask 112. As an additional safety precaution to make sure all ozone is released from the CPAP device 105 before a user utilizes the CPAP device 105, an oxidizing catalyst, such as an MgO filter, may be on the ozone device 100, such as on the back side of the mask compartment 116 to collect, breakdown and release remaining ozone as oxygen O2.


The ozone compartment 110, in accordance with the present embodiment of the present invention may be any available ozonator or a like device for creating ozone gas. Ozonators create ozone from oxygen molecules, often by applying ultraviolet light to the oxygen. Ozone gas is made of oxygen molecules that have been ionized by radiation to form groups of three oxygen atoms, O3. The ozone gas is powerful and effective for removal of odors, impurities and dangerous pathogens, working by exchanging electron charge with particles that ozone comes into contact with to form oxygen, O2, from the unstable ozone O3, a process particularly useful for purifying air and water and for killing bacteria and microorganisms. Typically, ozone, O3, will convert back to oxygen, O2, within two hours of the start of a cycle.


In accordance with the embodiment shown in FIG. 1, a small air pump is provided in the ozone compartment 110 to push ozone into the water reservoir 122. An exhaust port is further provided in the mask compartment 116 and has two main functions; the first is to draw the free ozone up into the hose 124 from the water reservoir 122 and into the mask 112 from the water reservoir 122. The free ozone will work to disinfect the water reservoir 122, the hose 124, and the mask 112. After exiting the mask 112 the free ozone then will be drawn out of the mask compartment 116 through the exhaust port into the free atmosphere as oxygen O2. Further shown in this embodiment is a user interface 111 for a user to set a sanitizing schedule on the ozone device 100 and a top cover 113 to close the ozone device 100.



FIG. 2 is a side view of a CPAP connector unit 230 attaching the ozone distribution line 218 from an ozone device to the water reservoir 222 of a CPAP device in accordance with another embodiment of the present invention. In accordance with this embodiment the ozone distribution line 218 is shown connected through the CPAP connector unit 230, at a ninety degree angle, and into the water reservoir 222. The ozone may be distributed from the ozone distribution line 218 into the water 219. The ozone 221 may effectively sanitize the water and kill bacteria and microorganisms in the water 219 by oxidizing organics in the water 219. Free ozone 221 that is left after removing organics from the water 219 in the water reservoir 222 may then release from the water and pass into the hose 224 to sanitize the hose and then enter a mask compartment for sanitizing a mask. By sanitizing the ozone water reservoir 222, the water 219, the hose 224 and the mask after each use, a user may effectively clean and sanitize their CPAP machines on a daily basis and use the machine with a decreased risk of discomfort, infection or bacteria growth in their CPAP device. While the CPAP device may still need to be cleaned in accordance with a manufacturer's requirements, the present invention will assist a user to maintain a safe to use device on a regular basis and improve compliance and use of the CPAP device to treat sleep apnea. The inventors expect that the current invention will assist people with sleep apnea to easily disinfect their CPAP device and use their machines safely in accordance with personal preferences and routine schedules.



FIG. 3 shows a front view of an ozone device 300 and a CPAP device 305 in accordance with another embodiment of the present invention. In accordance with this embodiment, an ozone operating system 315 may make ozone, which may enter the water 319 in the water reservoir 322 through the distribution line 318 and the CPAP connector unit 330. In accordance with this embodiment ozone enters the hose 324 as free ozone from the water reservoir 322, and the hose 324 carries the ozone gas to sanitize the mask 312 in the mask compartment 316. In accordance with this embodiment the ozone disinfects and sanitizes the entire CPAP device 305 for a user prior to use, including the water reservoir 322, the water 319, the hose 324, the mask 312 and the mask compartment 316. In accordance with this embodiment, the ozone may convert back to a stable form of oxygen after entering the mask compartment 316, making a user's CPAP device 305 easily disinfected and ready to use. In accordance with this embodiment an MgO exhaust port may be provided in the mask compartment 316 to collect, breakdown and release remaining ozone to the atmosphere, as an additional safety measure to make sure all ozone and free ozone is removed from the ozone device 300 prior to use. Further shown in this embodiment is a user interface 311 for a user to set a sanitizing schedule on the ozone device 300 and a top cover 313 to close the ozone device 300.



FIG. 4 shows a top view an ozone device 400 and a CPAP device 405 with the top covers removed for viewing the inner parts of the ozone device 400 and the CPAP device 405. In this embodiment, free ozone 421 is released from the water 419 and traverses into the hose 424. In accordance with the embodiment shown, the free ozone 421 will disinfect the water 419 and the hose 424. The free ozone 421 may continue to traverse from the hose 424 to the mask compartment 416 to further sanitize a mask 412, before exiting the ozone device 400 through an exhaust port. Further shown in this embodiment is a control panel 411 for a user to set ozone sanitizing schedules in accordance with a user's preferences.


In another embodiment of the present invention, shown in FIG. 5, a heater adapter unit 552 is connected to a CPAP connector unit 530 to connect a heating element 550 on a hose 524 to a heating element receptors 554 on a CPAP device 505. The heating element 550 may be used to heat a hose 524, to prevent condensation of water vapor as it passes through the hose 524. While heating elements 550 are commonly used on CPAP devices 505, in order to practice the present invention of providing ozone to the CPAP device 505 through an ozone distribution line 518 for sanitizing a CPAP device 505, a heating adapter unit 552 may be required to attach the CPAP connector unit 530 to a CPAP device 505 with heating systems. One method of heating the hose 524 includes but is not limited to passing a low voltage electric current through a resistive conductor such as copper or aluminum conductor wires 556, which may be woven along the length of a hose 524 and effectively heat the hose 524, as shown in FIG. 5. Another method of heating the hose 524 may include using a hose sleeve of Neoprene or fleece to cover the exterior of the hose 524, which may insulate the hose from external cold air. FIG. 5 shows an embodiment with copper conductor wires 556 woven around the hose 524 for heating the hose 524. In this embodiment the heating element 550 contains copper conductor wires which connects to copper receptors in the heating element receptor 554, generating electric heat to copper conductor wires 556 when the CPAP device 505 is in an on position. In this embodiment a CPAP connector unit 530 is shown for connecting an ozone device in accordance with the present invention to a CPAP device 505 to disinfect the CPAP device between uses. The heater adapter unit 552 is connected to the CPAP connector unit 530 for attaching the heating element 550 to the heating element receptor 554, as shown. In accordance with this embodiment of the present invention, systems, methods and devices to provide ozone to sanitize a CPAP device 505, hose 524 and water reservoir may be used in conjunction with heating elements for heating the hose 524. In this embodiment, the CPAP connector unit 530 provides for the flow of ozone into an ozone distribution line 518 into a water reservoir, and then into the hose 524 from the water reservoir, while the heater adapter unit 552 connects the copper wires in the heating element 550 to the corresponding contacts in the heating element receptors 554 of the CPAP device 505.



FIG. 5A shows in detail the connection of the copper wires in the heating elements 550 through the heating adapter unit 552 to the heater element receptors 554 on the CPAP device 505 in accordance with the embodiment described with reference to FIG. 5. In accordance with the embodiment shown, the heating adapter unit 552 is attached below the CPAP connector unit 530 and copper wires 556 are shown woven around the hose 524.



FIG. 6 shows a side view of yet another embodiment of the present invention shown in FIG. 6 a CPAP connector unit 630 for connecting a heating element 650 heating system for heating a hose 624 of a CPAP device with a heating element 650 and heating element receptors 654 is shown. In this embodiment, cold air in a room may cause condensation of water vapor in the hose 624 of the CPAP device and results in bacterial growth in the hose and in a facial mask. Heating the hose 624 helps prevent condensation of water vapor in the hose 624. In accordance with this embodiment, a heating element 650 is formed at the end of the hose 624, where the hose 624 connects to a CPAP device. In this embodiment, a CPAP connector unit 630 is shown connecting the heating element 650 to the CPAP device 605 so that ozone may be further added to the CPAP device through the ozone distribution line 618 in accordance with the present invention. In this embodiment the heating element 650 may work by passing a low voltage electric current through a resistive conductor which may be woven along the length of the hose effectively heating the hose.



FIG. 7 shows a side view of yet another embodiment of the present invention shown in FIG. 7 a heating system for heating a hose 724 with a heating adapter unit 752 connected to a CPAP connector unit 730 to provide ozone to a CPAP device 705 with heating systems embedded therein is shown. In this embodiment, the heating receptors 754 are located adjacent to a hose on a CPAP device 705 and may contain copper wires to transfer electric power from the heating element 750, attached to the hose 724. In accordance with this embodiment, the heating adapter unit 752 fits over the CPAP hose entry 758 and the heating receptors 754 on the CPAP device 705 so that the ozone technology in accordance with the present invention may be connected through the ozone distribution line 718 to the CPAP device 705, while the heating elements 750 already in place on the CPAP device 705 may still be connected through the heating adapter unit 752 to heat the hose 724. In accordance with this embodiment, cold air in a room may cause condensation of water vapor in the hose 724 of the CPAP device and result in bacterial growth in the hose and a facial mask. Heating the hose 724 helps prevent condensation of water vapor in the hose 724, while administering ozone to the CPAP reservoir and hose in accordance with the present embodiment automatically disinfects the CPAP machine and prevents bacterial and mold build-up.



FIG. 8 shows a perspective view of the present invention with the ozone device 800 connected to a CPAP device 805 with heating systems embedded in the CPAP device 805. In accordance with this embodiment, ozone is pumped from the ozone device 800 through an ozone distribution line 818 to the CPAP connector unit 830 to be released into the water reservoir 822. In this embodiment, a heating element 850 is provided on the hose 824 to connect to heating element receptors 854 on the CPAP device 805. In accordance with the embodiment shown, a heater adapter unit 852 is connected to the CPAP connector unit 830 to attach the heating element 850 to the heating element receptors 854. In accordance with this embodiment, the heating system may work to heat the hose 824 to prevent condensation of water during operation by heating copper wires 856 surrounding the hose. In addition, the ozone operating system in accordance with the present embodiment may sanitize the water reservoir 822, the hose 824, the mask 812 and the mask chamber 816 as shown.


In accordance with the embodiments shown, the ozone device will have a built-in timer so that a user can set the time to start the ozone disinfecting process at fixed time intervals. Typically, an ozone cycle is recommended at the end of each CPAP device use for best results for a consumer. The ozone device in accordance with one or more embodiments of the present invention will have a delayed start button, so that the CPAP device will not start until a fixed time has passed since the last ozone disinfecting process. In accordance with one or more embodiments, a one hour time period is implemented to prevent start of a CPAP device until one hour has passed from an ozone disinfecting process in accordance with one or more of the embodiments shown. In accordance with other embodiments a two-hour time period is implemented before the CPAP device can be used after an ozone disinfecting process in accordance with one or more embodiments of the present invention.


With reference to one or more embodiments shown, an ozone device is described including an ozone compartment, an ozone operating system, and one or more ozone distribution lines to distribute ozone through a CPAP device. A CPAP ozone air pump distributes ozone to the ozone distribution lines in one or more embodiments of the present invention. The ozone will migrate from the ozone distribution lines into the water reservoir of the CPAP device. The ozone will oxidize organic material in the water, thereby disinfecting water in the water reservoir. Remaining ozone will release as free ozone from the water reservoir and migrate as a gas into the attached hose, mask and mask compartment. An exhaust port in the mask compartment helps migrate free ozone into the hose, mask and mask compartment, and releases remaining ozone into the atmosphere as O2 oxygen from the mask compartment. The ozone O3 will disinfect the water reservoir, the hose, the mask and the mask compartment while the ozone migrates through the CPAP device in accordance with the embodiments of the present invention.


In addition to the device described and shown in the embodiments of the present invention, methods of disinfecting a CPAP device are further disclosed. In accordance with one embodiment, a method for disinfecting a continuous positive airway pressure may include the steps of producing ozone in an ozone device with an ozone operating system, releasing ozone into a continuous positive airway pressure device; and, migrating ozone through a continuous positive airway pressure device. In yet another embodiment, a method of disinfecting a CPAP device with an ozone device by releasing ozone into a CPAP connector unit, distributing ozone into a water reservoir, migrating free ozone from the water reservoir to a hose, migrating the free ozone into a mask in a mask compartment; and, removing the ozone from the CPAP device through an exhaust port, is described. The method disclosed further includes a step of delaying the start of a CPAP treatment for a fixed period of time from the last ozone disinfecting process for the safety of the consumers. The step of delaying the start time may range from about 30 minutes to 5 hours, depending on the embodiment implemented. In yet other embodiments the step of delaying the start time may range from about 5 hours to 10 hours. In addition the step of sensing remaining ozone in a CPAP device is an added step in one or more embodiments of the present invention for a consumer's safety prior to use. In addition, in one or more embodiments of the present invention, adding a safety switch in the mask compartment prevents starts of an ozone sanitizing process until the mask is returned by a user to the mask compartment. The safety switch is an additional precaution to prevent use of a CPAP device during an ozone disinfecting process.


In yet another embodiment of the present invention, as shown in FIG. 9, an improved CPAP face mask 960 and straps 962 are provided to maximize comfort of a patient during a CPAP procedure. In accordance with the embodiment, the straps 962 are cut on a bias to maintain elasticity and fluidity of the straps 962 as the strap rests along a user's head and face during a CPAP procedure.



FIG. 10 shows another embodiment of the present invention, where a side view of a facemask straps 1062 are provided. In accordance with this embodiment, the straps 1062 are cut on a bias cut, to maximize the elastic comfort of the straps 1062 for a patient. In accordance with this embodiment, the straps 1062 is made of one or more material(s) that are lightweight, breathable, washable and disposable, for ease of use by a user.


It should be emphasized that the above-described embodiments of the present invention, particularly, any “preferred” embodiments, are merely possible examples of implementations, merely set forth for a clear understanding of the principles of the invention. Many variations and modifications may be made to the above-described embodiments of the invention without departing substantially from the spirit and principles of the invention. All such modifications and variations are intended to be included herein within the scope of this disclosure and the present invention and protected by the following claims.

Claims
  • 1. A system comprising: an ozone device comprising an ozone operating system and an ozone distribution line;a connector unit configured to fluidly couple the ozone device to a continuous positive airway pressure (CPAP) device, the connector unit comprising: a first end comprising a first opening configured to couple to a reservoir of said CPAP device;a second end comprising a second opening configured to couple to a hose of said CPAP device;a first passageway extending between the first opening and the second opening, the first passageway defined at least in part by a wall of said connector unit, wherein said wall extends between the first end and the second end; anda port comprising a third opening that is configured to couple to the ozone distribution line and a second passageway, wherein the second passageway extends through the wall and is at least partially disposed within the first passageway.
  • 2. The system of claim 1, wherein: the first end of the connector unit is coupled to the reservoir via the first opening;the second end of the connector unit is coupled to the hose via the second opening;the second passageway is fluidly coupled to the ozone distribution line via the third opening; andin operation, ozone gas generated by said ozone device flows from said ozone operating system, through said ozone distribution line, into said second passageway via said third opening, and into said reservoir.
  • 3. The system of claim 1, wherein the second passageway bends within the first passageway.
  • 4. The system of claim 1, wherein: the first opening is oriented transverse to the second opening.
  • 5. The system of claim 4, wherein: the third opening is positioned substantially opposite the first opening.
  • 6. The system of claim 1, wherein the third opening is oriented transverse to one or both the first opening and the second opening.
  • 7. The system of claim 2, wherein the first passageway and the second passageway are in fluid communication with the reservoir.
  • 8. The system of claim 2, further comprising a mask connected to a distal end of the hose of said CPAP device.
  • 9. The system of claim 8, further comprising a gas-tight mask compartment configured to contain said mask.
  • 10. The system of claim 9, wherein said mask compartment further comprises an exhaust port.
  • 11. A connector unit, comprising: a first end comprising a first opening configured to couple to a reservoir of a continuous positive airway pressure (CPAP) device;a second end comprising a second opening configured to couple to a hose of said CPAP device;a first passageway extending between the first opening and the second opening, the first passageway defined at least in part by a wall of said connector unit, wherein said wall extends between the first end and the second end; anda port comprising a third opening configured to couple to a source of ozone gas and a second passageway, wherein the second passageway extends through the wall and is at least partially disposed within the first passageway.
  • 12. The connector unit of claim 10, wherein the second passageway bends within the first passageway.
  • 13. The connector unit of claim 10, wherein: the first opening is oriented transverse to the second opening.
  • 14. The connector unit of claim 13, wherein: the third opening is positioned substantially opposite the first opening.
  • 15. The connector unit of claim 10, wherein the third opening is oriented transverse to one or both the first opening and the second opening.
  • 16. The system of claim 1, wherein at least a portion of the wall is oriented transverse to the first opening and the second opening.
  • 17. The connector unit of claim 11, wherein at least a portion of the wall is oriented transverse to the first opening and the second opening.
  • 18. The system of claim 2, wherein in operation: ozone gas flows in a first direction into said reservoir from said second passageway; andozone gas flows in a second direction from said reservoir into said first passageway, wherein the second direction is different than the first direction.
  • 19. The system of claim 1, wherein at least a portion of the second passageway extends in a direction that is transverse to at least a portion of the first passageway.
  • 20. The connector unit of claim 11, wherein at least a portion of the second passageway extends in a direction that is transverse to at least a portion of the first passageway.
  • 21. A system comprising: an ozone device comprising an ozone operating system and an ozone distribution line;a connector unit configured to fluidly couple the ozone device to a continuous positive airway pressure (CPAP) device, the connector unit comprising: a first end configured to couple to a reservoir of said CPAP device, the first end comprising a first opening;a second end configured to couple to a hose of said CPAP device, the second end comprising a second opening;a first passageway extending between the first end and the second end of the connector unit, the first passageway defined at least in part by a wall of said connector unit; anda second passageway;
  • 22. A connector unit, comprising: a first end configured to couple to a reservoir of a continuous positive airway pressure (CPAP) device, the first end comprising a first opening;a second end configured to couple to a hose of said CPAP device, the second end comprising a second opening;a first passageway extending between the first end and the second end, the first passageway defined at least in part by a wall of said connector unit; anda second passageway, wherein:the second passageway: extends through the wall of said connector unit;is at least partially disposed within the first passageway;comprises a port that is configured to couple to a source of ozone gas; andthe first opening is oriented transverse to the second opening.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/441,929, filed Feb. 24, 2017, which is a continuation of U.S. application Ser. No. 15/142,111, filed Apr. 29, 2016 (now U.S. Pat. No. 9,610,373), which is a continuation of U.S. application Ser. No. 14/232,773, filed Jan. 14, 2014 (now U.S. Pat. No. 9,358,316), which is a 371 of international application no. PCT/US12/46593, filed Jul. 13, 2012, which claims priority to U.S. provisional application No. 61/508,341, filed Jul. 15, 2011, the entire content of each of which is incorporated herein by reference.

US Referenced Citations (97)
Number Name Date Kind
4019986 Burris Apr 1977 A
4035657 Carlson Jul 1977 A
4110419 Miller Aug 1978 A
4207291 Byrd et al. Jun 1980 A
4465522 Taldo et al. Aug 1984 A
4517159 Karlson May 1985 A
D295074 Jerge et al. Apr 1988 S
4743275 Flanagan May 1988 A
4787980 Ackermann et al. Nov 1988 A
5029879 Strang, Sr. et al. Jul 1991 A
5207237 Langford May 1993 A
5344622 Faddis et al. Sep 1994 A
5508006 Gabele et al. Apr 1996 A
5520893 Kasting, Jr. et al. May 1996 A
D371203 Deeds Jun 1996 S
D390645 Hanrahan et al. Feb 1998 S
5761069 Weber et al. Jun 1998 A
5920075 Whitehead Jul 1999 A
6024066 Nakayama et al. Feb 2000 A
6158784 Lavender Dec 2000 A
6276304 Tai Aug 2001 B1
6280633 Conrad et al. Aug 2001 B1
6379617 Spickermann Apr 2002 B1
6379632 Kinoshita et al. Apr 2002 B1
D476423 Picot et al. Jun 2003 S
6576190 Park Jun 2003 B1
6605260 Busted Aug 2003 B1
D487315 Picot et al. Mar 2004 S
6752151 Hill Jun 2004 B2
7022225 Clawson et al. Apr 2006 B1
7520910 Tilley Apr 2009 B2
7527603 An May 2009 B2
7676276 Karell Mar 2010 B2
7767168 Namespetra et al. Aug 2010 B2
7794522 Bliss et al. Sep 2010 B2
7845350 Kayyali et al. Dec 2010 B1
8051853 Berthon-Jones Nov 2011 B2
8146946 Emond Apr 2012 B1
8176771 Onishi et al. May 2012 B2
8431076 Fraundorfer Apr 2013 B2
D692155 Matoba et al. Oct 2013 S
8815164 Al Azemi Aug 2014 B1
D719673 Leyva et al. Dec 2014 S
D719674 Leyva et al. Dec 2014 S
8915380 Sowerby et al. Dec 2014 B2
9022247 Enigmann May 2015 B2
D733315 Lui Jun 2015 S
D733316 Lui Jun 2015 S
D748280 Lui Jan 2016 S
9358316 Leyva Jun 2016 B2
D761142 Golta et al. Jul 2016 S
D776290 Wan et al. Jan 2017 S
9610373 Leyva Apr 2017 B2
9616147 Leyva Apr 2017 B2
9669124 Leyva et al. Jun 2017 B2
D802788 Cormier et al. Nov 2017 S
9895461 Leyva et al. Feb 2018 B2
9907872 Schmidt et al. Mar 2018 B2
D819190 Cormier et al. May 2018 S
10052397 Leyva Aug 2018 B2
10232072 Leyva et al. Mar 2019 B2
10264913 Leyva Apr 2019 B2
20030000966 Shelton Jan 2003 A1
20030063997 Fryer et al. Apr 2003 A1
20030065292 Darouiche et al. Apr 2003 A1
20030065297 Davis et al. Apr 2003 A1
20030071069 Shelton Apr 2003 A1
20040251125 Yu Dec 2004 A1
20050017380 Namespetra et al. Jan 2005 A1
20050019237 Riley Jan 2005 A1
20050186108 Fields Aug 2005 A1
20050220665 Ding Oct 2005 A1
20060130834 Chen Jun 2006 A1
20060272682 Langford Dec 2006 A1
20070031778 Helfenbein et al. Feb 2007 A1
20070065335 Bedard et al. Mar 2007 A1
20080050290 Yui Feb 2008 A1
20090267242 Nichols Oct 2009 A1
20100111792 Nelson May 2010 A1
20100112677 Onishi et al. May 2010 A1
20100147302 Selvarajan et al. Jun 2010 A1
20120164025 Stockley, III et al. Jun 2012 A1
20120227745 Arcilla et al. Sep 2012 A1
20130239994 Przyjemski Sep 2013 A1
20140154134 Leyva Jun 2014 A1
20150004061 Kain et al. Jan 2015 A1
20160235875 Schmidt et al. Aug 2016 A1
20170165443 Leyva Jun 2017 A1
20170202990 Leyva Jul 2017 A1
20170209610 Leyva et al. Jul 2017 A1
20170224857 Leyva et al. Aug 2017 A1
20170225985 Leyva et al. Aug 2017 A1
20180161466 Schmidt et al. Jun 2018 A1
20190076561 Leyva et al. Mar 2019 A1
20190076562 Schmidt et al. Mar 2019 A1
20190083668 Schmidt et al. Mar 2019 A1
20190151487 Leyva May 2019 A1
Foreign Referenced Citations (15)
Number Date Country
1377708 Nov 2002 CN
2710637 Jul 2005 CN
201156965 Dec 2008 CN
105031693 Nov 2015 CN
2731632 Aug 2017 EP
2005270589 Oct 2005 JP
1020040098412 Nov 2004 KR
03068274 Aug 2003 WO
2008116165 Sep 2008 WO
2011058472 May 2011 WO
2013012696 Jan 2013 WO
2015171730 Nov 2015 WO
2017189915 Nov 2017 WO
2017189916 Nov 2017 WO
2018200525 Nov 2018 WO
Non-Patent Literature Citations (49)
Entry
CPAP Guardian TB-316, America Tyson Industrial Group (Asia Pacific) Limited, http://www.ecvv.com/products/2314441.html, Nov. 19, 2009, downloaded from internet Jul. 8, 2016. (Year: 2009).
Ozone MSDS (Material Safety Data Sheets), Ozone Solutions, Jun. 1, 2000, http://www.ozoneapplications.com/info/ozone_msds.htm, 5 pages.
CPAP Guardian TB-316, America Tyson Industrial Group (Asia Pacific) Limited, http://www.ecvv.com/products/2314441.html, Nov. 91, 2009, downloaded from Internet Jul. 8, 2016, 3 pages.
International Search Report and Written Opinion dated Sep. 17, 2012, issued in PCT Application No. PCT/US12/46593, 6 pages.
International Search Report and Written Opinion dated Jul. 24, 2015, issued in PCT Application No. PCT/US15/29418, 9 pages.
U.S. Office Action dated Jun. 30, 2016, issued in U.S. Appl. No. 15/141,216, 13 pages.
U.S. Office Action dated Jul. 13, 2016, issued in U.S. Appl. No. 15/142,060, 18 pages.
U.S. Office Action dated Jul. 14, 2016, issued in U.S. Appl. No. 15/142,111, 10 pages.
U.S. Office Action dated Jul. 28, 2016, issued in U.S. Appl. No. 15/142,085, 15 pages.
U.S. Office Action dated Oct. 6, 2016, issued in U.S. Appl. No. 15/141,152, 11 pages.
U.S. Office Action dated Nov. 23, 2016, issued in U.S. Appl. No. 15/141,216, 9 pages.
U.S. Office Action dated Nov. 23, 2016, issued in U.S. Appl. No. 15/142,085, 8 pages.
U.S. Office Action dated Feb. 23, 2017, issued in U.S. Appl. No. 29/562,755, 8 pages.
U.S. Office Action dated Feb. 27, 2017, issued in U.S. Appl. No. 29/562,756, 7 pages.
U.S. Office Action dated Mar. 17, 2017, issued in U.S. Appl. No. 15/141,152, 14 pages.
U.S. Office Action dated Jun. 13, 2017, issued in U.S. Appl. No. 15/481,919, 10 pages.
International Search Report and Written Opinion dated Aug. 2, 2017, issued in PCT Patent Application No. PCT/US17/29949, 11 pages.
U.S. Office Action dated Aug. 3, 2017, issued in U.S. Appl. No. 15/141,152, 14 pages.
International Search Report and Written Opinion dated Aug. 16, 2017, issued in PCT Patent Application No. PCT/US17/29950, 11 pages.
Office Action dated Sep. 21, 2017, issued in U.S. Appl. No. 15/142,085, 9 pages.
Notice of Allowance dated Oct. 13, 2017, issued in U.S. Appl. No. 15/481,919, 7 pages.
U.S. Final Office Action dated Feb. 5, 2018, issued in U.S. Appl. No. 15/141,152, 16 pages.
U.S. Office Action dated Apr. 3, 2018, issued in U.S. Appl. No. 15/873,506, 7 pages.
U.S. Notice of Allowance dated Apr. 27, 2018, issued in U.S. Appl. No. 15/142,085, 8 pages.
International Search Report and Written Opinion dated Jul. 13, 2018, issued in PCT International Patent Application No. PCT/US18/29140, 12 pages.
Office Action dated Aug. 9, 2018, issued in Japanese Patent Application No. 2014-520352, 5 pages. English language translation provided.
Office Action dated Sep. 5, 2018, issued in Chinese Patent Application No. 2016105175158, 10 pages. English language translation provided.
Office Action dated Sep. 17, 2018, issued in U.S. Appl. No. 15/441,929, 10 pages.
Examination Report dated Sep. 26, 2018, issued in Australian Patent Application No. 2017228723, 6 pages.
Office Action dated Oct. 30, 2018, issued in U.S. Appl. No. 15/499,456, 13 pages.
Notice of Allowance dated Oct. 31, 2018, issued in U.S. Appl. No. 15/873,506, 8 pages.
Office Action amendment dated Oct. 31, 2018, issued in U.S. Appl. No. 15/499,456, 13 pages.
Office Action dated Nov. 6, 2018, issued in U.S. Appl. No. 15/499,378, 18 pages.
Preliminary Report on Patentability dated Nov. 8, 2018, issued in PCT International Patent Application No. PCT/US2017/029949, 9 pages.
Preliminary Report on Patentability dated Nov. 8, 2018, issued in PCT International Patent Application No. PCT/US2017/029950, 9 pages.
Office Action dated Jan. 16, 2019, issued in Korean Patent Application No. 10-2018-7009274, 5 pages. English language translation provided.
Notice of Allowance dated Jan. 18, 2019, issued in U.S. Appl. No. 15/441,929, 7 pages.
Office Action dated Jan. 22, 2019, issued in U.S. Appl. No. 16/190,996, 10 pages.
Final Office Action dated Feb. 4, 2019, issued in U.S. Appl. No. 15/141,152, 14 pages.
Examination Report dated Feb. 15, 2019, issued in Australian Patent Application No. 2018200514, 5 pages.
Office Action dated Mar. 4, 2019, issued in U.S. Appl. No. 15/444,916, 16 pages.
Office Action dated Mar. 4, 2019, issued in U.S. Appl. No. 16/257,898, 13 pages.
Notice of Allowance dated Mar. 19, 2019, issued in U.S. Appl. No. 15/499,456, 12 pages.
U.S. Appl. No. 16/257,898, filed Jan. 25, 2019.
U.S. Office Action dated Jul. 26, 2019, issued in U.S. Appl. No. 16/190,996, 12 pages.
Notice of Allowability dated May 22 2019, issued in U.S. Appl. No. 15/499,456, 5 pages.
Notice of Allowance dated May 28, 2019, issued in U.S. Appl. No. 15/499,378, 7 pages.
Notice of Allowance dated Jun. 20, 2019, issued in U.S. Appl. No. 16/257,898, 8 pages.
Examination Report dated May 15, 2019, issued in Australian Patent Application No. 2017228723, 5 pages.
Related Publications (1)
Number Date Country
20190167828 A1 Jun 2019 US
Provisional Applications (1)
Number Date Country
61508341 Jul 2011 US
Continuations (3)
Number Date Country
Parent 15441929 Feb 2017 US
Child 16270141 US
Parent 15142111 Apr 2016 US
Child 15441929 US
Parent 14232773 US
Child 15142111 US